Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL754168 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL18380848 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL420986 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL312671 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL30782568 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL419968 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL754172 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL30133577 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| Bromide SCHEMBL31659017 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL193290 | 0.97 | APP (0.46) | APPLMNABLMPTGS1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7236 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130856-A1 | LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF | NANOTECH PHARMA INC (US) | 2026-05-14 | — | — | US | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-12616694-B2 | Pharmaceutical compositions for subcutaneous administration of levosimendan | TENAX THERAPEUTICS, INC. (US) | 2026-05-05 | — | — | US | claimed |
| WO-2026089751-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF CARNOSINE FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS | Finitus, LLC (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2026089754-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2026089752-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4678649-A1 | USE OF SUBSTITUTED CYCLODEXTRIN FOR VIRAL INACTIVATION IN BIOMANUFACTURING | ROQUETTE FRERES (FR) | 2026-01-14 | — | — | EP | claimed |
| EP-4674409-A1 | ORAL TABLETS FOR THE COLONIC DELIVERY OF THERAPEUTIC PROTEINS | ROQUETTE FRERES (FR) | 2026-01-07 | — | — | EP | claimed |
| US-20250367121-A1 | DOSAGE FORMS COMPRISING ACTIVE PHARMACEUTICAL INGREDIENTS | AXSOME THERAPEUTICS INC (US) | 2025-12-04 | — | — | US | claimed |
| US-12472255-B2 | Pharmaceutical compositions comprising meloxicam | AXSOME THERAPEUTICS, INC. (US) | 2025-11-18 | — | — | US | claimed |
| US-6294192-B1 | PHARMACEUTICAL COMPOSITIONS CAPABLE OF SOLUBILIZING THERAPEUTICALLY EFFECTIVE AMOUNTS OF HYDROPHOBIC THERAPEUTIC AGENTS. CARRIER INCLUDES A HYDROPHILIC SURFACTANT AND A HYDROPHOBIC SURFACTANT, AQUEOUS DISPERSION | LIPOCINE, INC. | 2001-09-25 | — | — | US | claimed |
| US-6267985-B1 | COMPOSITION COMPRISING TRIGLYCERIDE, CARRIER COMPRISING AT LEAST TWO SURFACTANTS, AT LEAST ONE BEING HYDROPHILIC, THERAPEUTIC AGENT CAPABLE OF BEING SOLUBILIZED IN TRIGLYCERIDE AND/OR CARRIER; FORMS CLEAR AQUEOUS DISPERSION | LIPOCINE INC. | 2001-07-31 | — | — | US | claimed |
| EP-1117442-A1 | DRY POWDER ACTIVE AGENT PULMONARY DELIVERY | Inhale Therapeutic Systems, Inc. (US) | 2001-07-25 | — | — | EP | claimed |
| WO-2001019339-A1 | FORMULATIONS FOR PARENTERAL USE OF ESTRAMUSTINE PHOSPHATE AND SULFOALKYL ETHER CYCLODEXTRINS | PHARMACIA ITALIA S.P.A. (IT) | 2001-03-22 | — | — | WO | claimed |
| WO-2001019338-A1 | FORMULATIONS FOR PARENTERAL USE OF ESTRAMUSTINE PHOSPHATE WITH IMPROVED PHARMACOLOGICAL PROPERTIES | PHARMACIA ITALIA S.P.A. (IT) | 2001-03-22 | — | — | WO | claimed |
| EP-1067942-A1 | HIGH-ENERGY CYCLODEXTRIN COMPLEXES | Cyclops, EHF. (IS) | 2001-01-17 | — | — | EP | claimed |
| WO-2001001960-A1 | CLEAR OIL-CONTAINING PHARMACEUTICAL COMPOSITIONS | LIPOCINE, INC. (US) | 2001-01-11 | — | — | WO | claimed |
| WO-2000050007-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF HYDROPHOBIC THERAPEUTIC AGENTS | LIPOCINE, INC. (US) | 2000-08-31 | — | — | WO | claimed |
| WO-2000015262-A1 | DRY POWDER ACTIVE AGENT PULMONARY DELIVERY | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 2000-03-23 | — | — | WO | claimed |
| WO-1999042111-A1 | HIGH-ENERGY CYCLODEXTRIN COMPLEXES | CYCLOPS, EHF. (IS) | 1999-08-26 | — | — | WO | claimed |